Surgenex Revenue and Competitors
Estimated Revenue & Valuation
- Surgenex's estimated annual revenue is currently $23.3M per year.
- Surgenex's estimated revenue per employee is $155,000
Employee Data
- Surgenex has 150 Employees.
- Surgenex grew their employee count by 38% last year.
Surgenex's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Chief Quality and Regulatory Officer | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | VP, Government Affairs and Health Policy | Reveal Email/Phone |
5 | VP Sales | Reveal Email/Phone |
6 | VP, National Accounts | Reveal Email/Phone |
7 | VP Business Development | Reveal Email/Phone |
8 | VP Phoenix Donor Services | Reveal Email/Phone |
9 | VP Sales | Reveal Email/Phone |
10 | Senior Director, Market Access and Health Policy | Reveal Email/Phone |
Surgenex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $6.4M | 41 | 0% | N/A | N/A |
#5 | $2.3M | 15 | -6% | N/A | N/A |
#6 | $1.1M | 7 | 0% | N/A | N/A |
#7 | $0.9M | 6 | 0% | N/A | N/A |
#8 | $2.7M | 35 | 21% | $58.2M | N/A |
#9 | $209.7M | 1353 | -3% | N/A | N/A |
#10 | $0.9M | 6 | 0% | N/A | N/A |
What Is Surgenex?
SURGENEX® is the producer and distributor of the highest quality amniotic membrane tissue allografts in the industry. Human Amniotic Tissue (hAM) is used in a wide variety of clinical settings including: Orthopaedics Sports Medicine Podiatry Pain Management Joint Care SURGENEX® has developed innovative processes and safety protocols, which deliver the highest quality and safety standards. With these safety and quality standards, SURGENEX® is the leader of amniotic membrane tissue allografts in the field of regenerative medicine. The SURGENEX® proprietary Excellion® process is used to produce SurForce®. This patented process is a highly manual and surgical harvesting procedure which generates the highest yield of amniotic tissues. Our placenta recovery processes start where life begins. Qualified mothers donate their placenta for medical treatments and research. These donors are selected through a strict screening process which includes an extensive patient questionnaire, serological testing, and a medical staff interview to ensure donor eligibility. The Excellion® process honors these donations by meticulously collecting the amniotic membrane and carefully removing unwanted tissues such as the chorion. This highly technical process produces the highest quality and the best amniotic tissue allograft in the industry. Learn more at surgenex.com and surgenexcatalog.com!
keywords:N/AN/A
Total Funding
150
Number of Employees
$23.3M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $44.1M | 152 | -6% | $15.6M |
#2 | $25.2M | 152 | 23% | N/A |
#3 | $27.3M | 152 | 6% | N/A |
#4 | $29.3M | 153 | 5% | N/A |
#5 | $37.5M | 155 | 41% | N/A |